Z17.42

Clinical Causes: Genetic mutations that alter hormone receptor expression Certain subtypes of breast cancer that inherently lack hormone receptors Environmental factors influencing gene expression related to hormone receptors Previous treatments that might affect receptor status, though typically this classification is based on initial tumor profile

Key Symptoms: Lumps or masses in the breast Changes in breast size or shape Skin changes on the breast, such as dimpling or redness Nipple discharge or inversion Pain or tenderness in the breast area

Diagnosis Path: Diagnosis involves a combination of physical examination, imaging tests such as mammography or ultrasound, and tissue biopsy. The biopsy provides a sample of the tumor, which is then tested for hormone receptor status through immunohistochemistry. The absence of estrogen and progesterone receptors identifies the tumor as hormone receptor negative. This classification aids in determining the most effective treatment options and prognosis.

Treatment Protocols: Treatment strategies for hormone receptor negative breast cancer often include a combination of therapy options, tailored to the patient's overall health and tumor characteristics. Common approaches include: - Surgical removal of the tumor or entire breast (mastectomy) - Chemotherapy to target rapidly dividing cancer cells - Targeted therapies, if applicable - Radiation therapy following surgery in some cases Since hormone therapy like tamoxifen or aromatase inhibitors is ineffective for hormone receptor negative cancers, treatment focuses on other modalities to control and eradicate the disease.